EUVIMEDEUVIMED entdecken
Crossref

Pulmonary Fibrosis in COVID-19 Patients

Eslami Vahid, Farokhnejad Somaye, Faghihi LangroudiTaraneh, Javad Karami Eshkaftaki, Kashefizade Alireza, Gachkar Latif

Mathews Journal of Cardiology · 2023

DOI: 10.30654/mjc.10029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathews Journal of Cardiology, 2023. Verfasst von Eslami Vahid und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Early analysis suggests the prevalence of post COVID 19fibrosis is approximately a fifth to a third of cured patients and 7%-8% are severe.Initiation and advancement of pulmonary fibrosis is caused by inflammation.

Method

In brief, the study population included 107 patients with a history of admission with COVID-19 infection diagnosis to

Zitieren

APA

Vahid, E., Somaye, F., LangroudiTaraneh, F., Eshkaftaki, J. K., Alireza, K., & Latif, G. (2023). Pulmonary Fibrosis in COVID-19 Patients. Mathews Journal of Cardiology. https://doi.org/10.30654/mjc.10029

Vancouver

Vahid E, Somaye F, LangroudiTaraneh F, Eshkaftaki JK, Alireza K, Latif G. Pulmonary Fibrosis in COVID-19 Patients. Mathews Journal of Cardiology. 2023. doi:10.30654/mjc.10029

BibTeX
@article{Vahid2023,
  author = {Vahid, Eslami and Somaye, Farokhnejad and LangroudiTaraneh, Faghihi and Eshkaftaki, Javad Karami and Alireza, Kashefizade and Latif, Gachkar},
  title = {Pulmonary Fibrosis in COVID-19 Patients},
  journal = {Mathews Journal of Cardiology},
  year = {2023},
  doi = {10.30654/mjc.10029}
}
Kostenlos starten →